International AIDS Conference: "Treatment Access, TRIPS and Trip-ups"

Schering-Plough did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Schering-Plough - finds none has comprehensive approach.

Дата:: 4 Мар 2014
Тип содержимого:: Ответ компании

Доступные языки: English

[PDF] Benchmarking AIDS: 2006 Year End Update

Дата:: 30 Ноя 2006
Тип содержимого:: Статья

Доступные языки: English

Response by Merck: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Merck - finds none has comprehensive approach.

Дата:: 13 Сен 2006
Тип содержимого:: Ответ компании

Доступные языки: English

Response by Wyeth (part of Pfizer): Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Wyeth - finds none has comprehensive approach.

Дата:: 13 Сен 2006
Тип содержимого:: Ответ компании

Доступные языки: English

Response by Bristol-Myers Squibb: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Bristol-Myers Squibb - finds none has comprehensive approach.

Дата:: 13 Сен 2006
Тип содержимого:: Ответ компании

Доступные языки: English

Company responses to Interfaith Center on Corporate Responsibility report "Benchmarking AIDS"

Дата:: 12 Сен 2006
Тип содержимого:: Статья

Доступные языки: English

Response by Boehringer Ingelheim: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Boehringer-Ingelheim - finds none has comprehensive approach.

Дата:: 6 Сен 2006
Тип содержимого:: Ответ компании

Доступные языки: English

Response by AstraZeneca: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including AstraZeneca - finds none has comprehensive approach.

Дата:: 6 Сен 2006
Тип содержимого:: Ответ компании

Доступные языки: English

Reclaman mayor compromiso de las farmacéuticas

Дата:: 31 Авг 2006
Тип содержимого:: Статья

Доступные языки: español

Eli Lilly did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Eli Lilly - finds none has comprehensive approach.

Дата:: 23 Авг 2006
Тип содержимого:: Ответ компании

Доступные языки: English

Response by Pfizer: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Pfizer - finds none has comprehensive approach.

Дата:: 23 Авг 2006
Тип содержимого:: Ответ компании

Доступные языки: English

Response by Novartis: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Novartis - finds none has comprehensive approach.

Дата:: 23 Авг 2006
Тип содержимого:: Ответ компании

Доступные языки: English

International AIDS Conference: "Treatment Access, TRIPS and Trip-ups"

Дата:: 17 Авг 2006
Тип содержимого:: Статья

Доступные языки: English

[PPT] presentation: "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets"

Дата:: 17 Авг 2006
Тип содержимого:: Статья

Доступные языки: English

New Report: Top pharma companies fail to address industry best practices on HIV/AIDS

Дата:: 14 Авг 2006
Тип содержимого:: Статья

Доступные языки: English

Sanofi-Aventis did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including sanofi-aventis - finds none has comprehensive approach.

Дата:: 1 Авг 2006
Тип содержимого:: Ответ компании

Доступные языки: English

Schering-Plough did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Schering-Plough - finds none has comprehensive approach.

Дата:: 1 Авг 2006
Тип содержимого:: Ответ компании

Доступные языки: English

Hoffmann-La Roche (part of Roche) did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Hoffman-La Roche - finds none has comprehensive approach.

Дата:: 8 Янв 2006
Тип содержимого:: Ответ компании

Доступные языки: English

Gilead Sciences did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Gilead - finds none has comprehensive approach.

Дата:: 8 Янв 2006
Тип содержимого:: Ответ компании

Доступные языки: English

Business & Human Rights
Resource Centre

Ресурсный центр по вопросам бизнеса и прав человека

Эта страница недоступна на Русский и отображается на English

International AIDS Conference: "Treatment Access, TRIPS and Trip-ups"

Хронология

Schering-Plough did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Schering-Plough - finds none has comprehensive approach.

[PDF] Benchmarking AIDS: 2006 Year End Update

Response by Merck: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Merck - finds none has comprehensive approach.

Response by Wyeth (part of Pfizer): Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Wyeth - finds none has comprehensive approach.

Response by Bristol-Myers Squibb: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Bristol-Myers Squibb - finds none has comprehensive approach.

Company responses to Interfaith Center on Corporate Responsibility report "Benchmarking AIDS"

Response by Boehringer Ingelheim: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Boehringer-Ingelheim - finds none has comprehensive approach.

Response by AstraZeneca: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including AstraZeneca - finds none has comprehensive approach.

Reclaman mayor compromiso de las farmacéuticas

Eli Lilly did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Eli Lilly - finds none has comprehensive approach.

Response by Pfizer: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Pfizer - finds none has comprehensive approach.

Response by Novartis: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Novartis - finds none has comprehensive approach.

International AIDS Conference: "Treatment Access, TRIPS and Trip-ups"

[PPT] presentation: "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets"

New Report: Top pharma companies fail to address industry best practices on HIV/AIDS

Sanofi-Aventis did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including sanofi-aventis - finds none has comprehensive approach.

Schering-Plough did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Schering-Plough - finds none has comprehensive approach.

Hoffmann-La Roche (part of Roche) did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Hoffman-La Roche - finds none has comprehensive approach.

Gilead Sciences did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Gilead - finds none has comprehensive approach.